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b. Prenyl transferases 
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c. Localization of GTPases depends on prenylations 
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d. Prenylation inhibitors  
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2. Other types of programmed cell death 
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3. Caspases – triggering and executing apoptosis  
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a) Modifications and subcellular localization 
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b) Described functions of RhoB 
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c) RhoB modifying toxins C3 + lethal toxin 
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6. Skeletal muscle 
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-17(3)-(.17:# =6&# ,&-174# (/0&# 12# ,(3.)(&4# *+,-'&# 51+'4# 8&# (6&# 6&)3(# *+,-'&# 56.-6# .,#
.791'+7()3.'/# -17(31''&4:# $*11(6# *+,-'&,# >21+74# .7# )3(&3.&,?# (6&# ;),(31.7(&,(.7)'# (3)-(?#
&(-:@# -)7# )',1# 71(# 8&# )38.(3)3.'/# -17(31''&4# 8+(# (6&.3# ,(3+-(+3&# )74# 2+7-(.17# .,#
2+74)*&7()''/#4.22&3&7(#231*#,%&'&()'#)74#6&)3(#*+,-'&:#
#
$%&'&()'#*+,-'&,#-)7#8&#4&9.4&4# .7(1# 3&4# )74#56.(&#*+,-+')(+3&?# (6&# 3&4# (/0&# >,'15A






















$%&'(')&*%+,-# ./)0,'# 0',,)# 123'# ./,&*4,'# %/0,'*# 51*01# 2('# ,602&'7# 2&# &1'# 86(7'(# 69#
./)0,'#9*8('):#;/(*%+#'.8(-6%*0#7'3',64.'%&#./)0,'#0',,)#2,*+%#&6#'201#6&1'(#2%7#9/)'#
&6#2#./&*%/0,'2(#0',,#02,,'7#.-6&/8'#6(#)-%0-&*/.:#<1/)=#*&#*)#%6&#46))*8,'#96(#2#.-6&/8'#
&6# 7*3*7':# $%)&'27# &1'-# +(65# 8-# 4(67/0*%+# %'5# 6(+2%',,')# ,*>'# &1'# '%'(+-# 4(63*7*%+#
.*&6016%7(*2:#
#






+'%'(2,# &'(.# *%0,/7*%+# 0(2.4)=# )&*99%'))# 2%7# )42).# 2)# 5',,# 2)# 7-)&(641*')=#
(12876.-6,-)*)#2%7#.2%-#6&1'(#.-642&1*'):##
#
?/)0,'# *%9,2..2&*6%# *)# ('9'(('7# &6# 2)#.-6)*&*):#?2%-#)/01#06%7*&*6%)#2('#06%)*7'('7#






D*%0'# 7')&(/0&*6%# ,'27)# &6# (','2)'# 69# &1'# 06%&'%&# 69# 72.2+'7# ./)0,'# 0',,)# *%&6# &1'#
8,667)&('2.#(12876.-6,-)*)# *)#2#(*)># 96(#20/&'#('%2,# 92*,/(':#?-6+,68*%# 96(#'E2.4,'# *)#




*%0,/7'# ./)0,'# '%G-.'# 7'9*0*'%0*')=# ','0&(6,-&'# 28%6(.2,*&*')=# *%9'0&*6/)# 02/)')=#














)4# 9+-+.*# +,'-+'&# &.44','*+.-+'&# A1(-*# 9=># ;'55%@# C*# ),&',# +)# 41,+A',# '51;.&-+'# +A'#
()5';15-,#-;+.)*#)4#9+-+.*#.*&1;'&#(B)+)D.;.+B#+A'#4)55)2.*:#E1'%+.)*%#-,'#,-.%'&F#
#
- GA.;A# /,)+'.*%# -,'# .*0)50'&# .*# 9+-+.*# .*&1;'&# -/)/+)%.%# -*&# 2A.;A# /-+A2-B%#
-,'#,'5'0-*+H#
#











Cell culture of primary cells 
$%%# &'(&)*+&,-.# /&)&# 01))*&2# 34-# /*-5# 2*66&)&,-*1-&2# ()*+1)7# 54+1,# .8&%&-1%# +4.0%&#
0&%%.# 39-1*,&2# 6)3+# .8&%&-1%# +4.0%&# 9*3(.*&.# 36# 5&1%-57# *,2*:*241%.# /53# 4,2&)/&,-#
2*1;,3.-*0# -&.-*,;.<# =5&# %&6-3:&)# +1-&)*1%# >"??@A??# +;B# /1.# 4.&2# -3# *.3%1-&# .1-&%%*-&#
0&%%.<#=5&#()30&24)&#/1.#1(()3:&2#97#-5&#%301%#&-5*0#03++*--&&#
36# -5&# C&2*01%# D,*:&).*-7# 36# E*&,,1# >F)<# G&*;%H# F&(1)-+&,-# 36# $,1&.-5&.*3%3;7I#
J&,&)1%# K3.(*-1%I# E*&,,1I# $4.-)*1B<# L1-&%%*-&# 0&%%.# /&)&# 8&(-# *,# ;)3/-5# +&2*4+# 1,2#














F*66&)&,-*1-&2# 54+1,# .8&%&-1%# +4.0%&# 0&%%.# /&)&# +1*,-1*,&2# *,# -5&# 19.&,0&# 1,2#
()&.&,0&#36#.-1-*,.I#-3'*,.I#+&:1%3,*0#10*2I#%*(*2.#>JJXXI#NXXB#1,2#01.(1.&#*,5*9*-3).#
1-#03,0&,-)1-*3,.#1,2# *,0491-*3,# -*+&.# *,2*01-&2# *,# -5&# )&.(&0-*:&# 6*;4)&.<#=5&)&16-&)I#
-5&# 0&%%.# /&)&# /1.5&2# /*-5# (53.(51-&O9466&)&2# .1%*,&# >XVLB# 1,2# %7.&2# /*-5# *0&O03%2#
01.(1.&O%7.*.#9466&)#.4((%&+&,-&2#/*-5#()3-&1.&#*,5*9*-3).#>"<A!;R+%#1()3-*,*,I#"?!;R+%#
%&4(&(-*,I#1,2#"??!C#(&619%308B<#C*0)3.3+1%#6)10-*3,.#1,2#07-3.3%#/&)&#.&(1)1-&2#97#
0&,-)*64;1-*3,# 1-# API???!"1-# AYZ# 63)# M?#+*,<# =5&#(&%%&-#/1.# )&.4.(&,2&2# *,# 01.(1.&#
%7.*.#9466&)I#1,2#.1+(%&.#/&)&#.-3)&2#1-#@T?YZ<#X)3-&*,#03,0&,-)1-*3,#/1.#2&-&)+*,&2#






















Western Blot  





B5-#,5L\N#:-22/# %9$*#!M(:*#:-22# :82489-# ,./5-/#0-9-#0+/5-,# 40.:-#0.45# GSLP# A-22/#








2$+,-,#0.45#5.35-/4#;$//.62-#1$28*-/#$%#;9$6-/# <"'E!'#!JOP#D8)).)3# 68%%-9# <'M'"(#N#
B9./F# 'M>^"# N# Y27:.)M# 'M>([# LXLO# 0+/# ;9-:$$2-,# 4$# &_AP# Y-2/# 0-9-# 98)# +4# >''?#
</4+:H.)3# 3-2O# U# >!'?# </-;+9+4.)3# 3-2O# %$9# +;;9$TP# >"'# *.)84-/P# Y-2/# 0-9-# /4$;;-,#
/5$9427#6-%$9-# 45-#628-#,7-#0+/# 98)).)3#$84P#I2-:49$;5$9-/./#0+/#:+99.-,#$84#$)#S@CE
!!"
#$%" &''()&*+)(," &-." ')/*(0-" .011+,0/-" 2&," 3/2()(." 45" 6/-,*&-*" 6//30-7" /1" *8("
&''()&*+)("20*8"06(9"
"
 separating gel stacking gel 
 12%  5%  
H2O 3,24 ml 2,785 ml 
30%-0.8% Acryl-Bisacryl 4 ml 0,835 ml 
1,5M Tris pH 8.8 2,5 ml ---   
0,5M Tris pH 6.8 ---   1,25 ml 
10% SDS 100 !L 50 !L 
10% APS 150 !L 75 !L 
TEMED 10 !L 5 !L 





C68+(33>" %&,,(3>" E();&-5F" 0-" ')(6//3(." *)&-,1()" 4+11()" <G)0," <A?;HF>" H(*8&-/3" <I?J
!?KF>"E3560-"<@?;HFF"&*"L??M"1/)"N?JO?";0-+*(,9""
:)(30;0-&)5"')/*(0-",*&0-0-7"2&,"./-("45"0-6+4&*0-7"*8(";(;4)&-("0-":/-6(&+"C"1/)"L?"
;0-+*(," &-." 6/3/)0-7"2&," )(;/P(."20*8"H0330Q"2&*()9"#(;&0-0-7" ')/*(0-" 0-":$$"7(3,"





H(;4)&-(," 2()(" 43/6U(." 20*8" AK" VC$" 1/)" !?JN?" ;0-+*(,9" :)0;&)5" &-*04/.0(," 2()("
0-6+4&*(." 1/)" L" 8/+)" &*" )//;" *(;'()&*+)(" <$6*0->" G+4+30-F>" &*" 3(&,*" @" 8/+)," &*" )//;"










01$%(' 23+4' 56678/" :/3563/-&3" )&440*" T7E" &-*04/.5B" .03+*(." LZIA?B" C&-*&" X)+="
V0/*(68-/3/75>"T-69>"C&-*&"X)+=>"X$"
!"#










C&./N*%+,-# G1-;/O-1# K;%*# ,>--I@# 1/(+.-1# 4548B888J# )&1# )&./N;)00/.# G1-;/O-1# K;%*#
1%&H-2@# 1/(+.-1# 4568B888J# )&./0%1/-,# K;%*# C*-;,>)*# =/%,'/-&'-,# '%&P+?).-1# Q/.>#
>%;,-;)1/,>#I-;%R/1),-B-#
#







Z6@7*$# [;/,NU:(# 0+KK-;# IU# Z@\J# K%;# 68N!8# */&+.-,B# CK.-;# ,.;/II/&?@#*-*0;)&-,# Q-;-#




F;%.-/&# ,.)&1);1,# %0.)/&-1# K;%*# C*-;,>)*# =/%,'/-&'-,@# ^W# Q-;-# +,-1# K%;# I;%I-;#
0)&1#),,/?&*-&.5##
L%Q#*%(-'+();#Q-/?>.5#4"@"#_#68@4#_#!8#_#"7#_#ZZ#_#`\#HE)#










$%&# '(()*%+',-%.+/(',-&01#2'33/&/*-'4-/2#+)(4*# ,5/6/-46#(),.6/#./66,#7/&/# 3'8/2#7'-+#
9:# ;4&43%&(462/+02/# 3%&# !<# ('*=# >+/# ./66,# 7/&/# 74,+/2# 7'-+# "<(?# @A9B6# 4*2#
,)C,/D)/*-60#;/&(/4C'6'E/2#3%&#"#('*#7'-+#4#,%6)-'%*#.%*-4'*'*F#<=G:#>&'-%*#HIG<<#4*2#
<=G:# .'-&4-/# '*# ;+%,;+4-/IC)33/&/2# ,46'*/=# >+/# ./66,# 7/&/# C6%.5/2# 7'-+# J:# C%K'*/#
,/&)(#46C)('*=##
L66#4*-'C%2'/,#7/&/#2'6)-/2#GMJ<<#4*2#'*.)C4-/2#3%&#G#+#4-#!NOB=#P(()*%,-4'*'*F#%3#./66,#




3'&,-# 4*-'C%20=# P(4F/,# 7/&/# .%66/.-/2# ),'*F# 4# .%*3%.46# ('.&%,.%;/# 3&%(# B4&6# Z/',,#
R[/*41# \/&(4*0V# /D)';;/2# 7'-+# 4*# 4&F%*# 64,/&# ,0,-/(# RY]?# 9G<V=# >+/# 2'F'-'E/2#
;'.-)&/,# 7/&/# ,-%&/2# 4*2#4*460E/2# %33I6'*/# ),'*F#X+%-%,+%;# RL2%C/#]0,-/(,#\(CA1#
?)*'.+1#\/&(4*0V#4*2#P(4F/[#,%3-74&/=#
#
Plasmid extension in E. coli 
>+/# ^+%# C'*2'*F# 2%(4'*# %3# ^+%-/5'*# R\]>I^+%-/5'*# ^T_# ;)662%7*# 4,,40V# 74,#
/8;&/,,/2# 4,# 4# &/.%(C'*4*-# 3),'%*# 7'-+# \]># '*# !"#$%&'#$'() #*+'=# >+/# !,) #*+'# ,-&4'*#
.%*-4'*'*F# -+/# ;64,('2# 7'-+# -+/#^+%-/5'*# ^+%# C'*2'*F# 2%(4'*# R^T_V# 74,# 4# 5'*2# F'3-#





-+/*# '*2)./2# 7'-+# <1"(?# PX>\# 3%&# J# +%)&,# 4-# !NOB=# T4.-/&'4# 7/&/# ,;)*# 2%7*# 4-#
"<<<&;(# 3%&# J<# ('*# 4-# 9OB# 4*2# &/,),;/*2/2# '*# b<# (6# C4.-/&'4# 60,',# C)33/&=# Y0,4-/,#
7/&/# -+/*# ,%*'.4-/2# Rb# 8# G"# ,/.1# J":# ;%7/&1# c<:# .0.6/V# %*# './# 4*2# .6/4&/2# C0#
./*-&'3)F4-'%*#RJ<=<<<F1#J<#('*V=#]);/&*4-4*-,#7/&/#-+/*#&%-4-/2#7'-+#J(6#R7/-#K%6)(/1#
"<M"<V#F6)-4-+'%*/#C/42,#R]'F(4V#3%&#J#+%)&,#4-#9OB=#$%66%7'*F1#C/42,#7/&/#74,+/2#,'8#
















GST-Rhotekin RBD binding assay 
6L(#NLIO5#&(++-#P()(#+,-(N#%-#N(-&)*.(N#0>)#'L(#&%-8%-(#%--%,-Q#R88)>S*4%'(+,#:3=#
>0#'L(#NLIO5#-/8()?%'%?'-#P%-#*?&/.%'(N#P*'L#TI6AU$F#.(%N-#>?#VWC#0>)#X3#4*?/'(-#
YZ>+/4(-# -8(&*0*(N# 0>)# (%&L# (S8()*4(?'[Q# R0'()# *?&/.%'*>?7# -/8()?%'%?'-# P()(#
&>48+('(+,# )(4>Z(N#%?N#.(%N-#P()(#P%-L(N#>?&(#P*'L# 233!\#P%-L*?D# ./00()#PL*&L#
P%-# 'L(?#%+->#&>48+('(+,# )(4>Z(NQ#!3AX3!\#>0#<#S#-%48+(#./00()#P%-# 'L(?#%NN(N# '>#
'L(# .(%N-# %?N# L(%'(N# '># X2WC# 0>)# <3# 4*?/'(-Q# $(%N-# P()(# -8/?# N>P?# %?N# 'L(#
-/8()?%'%?'# 8/'# >?# %# <E=# HRR# D(+# 0>)# (+(&')>8L>)(-*-# %?N# %# &>48+('(# P(-'()?# .+>'#
8)>&(N/)(#0>)#N('(&'*>?#>0#%&'*Z%'(N#UL>$Q##
DNA-chip analysis 
R#&>?&(?')%'*>?# -()*(-# P*'L# <!5#%?N#<3!5#I*4Z%-'%'*?# YI*4[# %?N#%# '*4(# -()*(-# P*'L#
<3!5#I*4#P*'L#*?&/.%'*>?#'*4(-#>0#EL7#<EL#%?N#EVL#P()(#8()0>)4(N#>?#NLIO5#&(++-#*?#
'P># -(8%)%'(# (S8()*4(?'-# %-# +*-'(N# *?# 'L(# '%.+(# .(+>PQ# RNN*'*>?%++,# &(++-# P()(#
Y-*4/+'%?(>/-+,[#')(%'(N#P*'L#<45#4(Z%+>?*&#%&*N#Y5R[Q##
#
# !"#$%&'(#!)# *!"#$%&'(#!)# !+"#$%&'(#!)# !+"#$%&'(#*)#
,-./0-1# !# !# !# !#
*2!3#456# !# !# !# !#
*!3#456# AAA# AAA# AAA# !#
*2!3#456#7#*63#38# !# !# !# !#
*63#38# !# !# !# !#
#
UBR#8/)*0*&%'*>?#
UBR#P%-#8/)*0*(N# 0)>4# NLIO5#&(++-# /-*?D#]*%D(?#UB(%-,^#5*?*# _*'Q# 6L()(0>)(# &(++-#



































$%%&'()*+,# -./0(# 1(2/'(# 34$56.+78# -(*(# 98(:# )/# /;)<+2# (,7*(88+/2# =<09(8# /%# <00#
.9'<2# 1(2(8# +2# :+%%(*(2)+<)(:# .9'<2# 8>(0()<0# '9860(# 6(008# ?.@ABC# 92:(*# :+%%(*(2)#
)*(<)'(2)# 6/2:+)+/28D# E2# <# %+*8)# (,7(*+'(2)# <# 6/26(2)*<)+/2# 8(*+(8# /%# @+'=<8)<)+2# -<8#
7(*%/*'(:#<%)(*#FG#./9*8#/%#)*(<)'(2)D#$#)+'(#8(*+(8#/=(*#F.H#IF.#<2:#FG.#-<8#6<**+(:#
/9)# +2# <# 8(6/2:# (,7(*+'(2)# %/*# IJ!B# @+'=<8)<)+2D# K(008# )*(<)(:# -+).# ).(# 8<'(#
6/2:+)+/28# <8# :(86*+;(:# -(*(# <::+)+2<00&# )*(<)(:# -+).# '(=<0/2+6# <6+:D# L.+8# <00/-8# )/#
%+0)(*#%/*#0+7+:#+2:(7(2:(2)0&#*(190<)(:#1(2(8D##
#
M(#98(:#NB$#O,7*(88# 8/%)-<*(# )/# /;)<+2# (,7*(88+/2# =<09(8# %*/'# *<-#:<)<# %+0(8D#$2#




T+*8)H# <# :+*(6)# 8(<*6.# %/*# 87(6+%+6# *(190<)+/2# 7<))(*28# -<8# 7(*%/*'(:D# L.(*(%/*(# ).*((#
7<))(*28#-(*(#6*(<)(:U##









*(190<)(:# 1(2(8# -<8# <770+(:# )/# ).(# IJJP# 1(2(8D# L.(# '()./:# 98(:# %/*# :+8)<26(#
'(<89*+21# -<8# 7(<*8/2# 6/**(0<)+/2D# W2(# /%# ).(# /;)<+2(:# 6098)(*8# 8./-(:# ).(#
7*/7(*)+(8#/%# 0+7+:#:(7(2:(2)#*(190<)+/2#<2:#<00#/%# +)8#!X#1(2(8#-(*(#<08/#6/2)<+2(:# +2#












   -    1     1    10   10    -   Sim 











































3456&! 78! /&9:6(9! -;! %#<&.(! .6:9(&<! 9&4<.=! >-;;#.#46! ?&'&! 9@*5-69A8# +EF# 2FGHIJG# KLGMINOFK#
PF2F#1QJNLRFK#PLJE# S>HIJL6TMF2LUFRJ#5LFPF2VW#%&&8#GJ21RXIO# 2FXHINJFK#XFRFG#PF2F# 3FFKFK# LRJ1#
JEF#G13JPN2F#NRK#UNJYEFK# 312# JE2FF#KL33F2FRJ# 2FXHINJL1R#MNJJF2RG#PLJE#N#M$ZNIHF#13#NJ# IFNGJ#&[%W#
+EF# MNJJF2RG# N2F# X2NMELYNIIO# KLGMINOFK# LR# JEF# 3L2GJ# Y1IHURW# <LXEF2# K1JG# 2FM2FGFRJ# N# 2FINJLZFIO#
GJ21RXF2# 2FXHINJL1RW# )LUZNGJNJLR# \)LU]# LR# !>[# UFZNI1RLY# NYLK# \>']# LR# U>W# !"#"$% $&#&'$&'(^#
_M2FXHINJL1R# LG# M2FZFRJFK# QO# GLUHIJNRF1HG# >'# J2FNJUFRJW# !"#"$% "'$&#&'$&'(^# >'# ENG# R1#
M2FZFRJLRX# F33FYJ# 1R# # )LUZNGJNJLR# LRKHYFK# HM2FXHINJL1RW# 'M1MJ1JLY^# )J21RX# HM2FXHINJL1R# HRKF2#
%!># )LU[# R1# KFJFYJL1R# N3JF2# %&!># )LUW# >'# MN2JIO# M2FZFRJG# Y1UMIFJF# K1PR2FXHINJL1R# HRKF2#

















!"#$%& '()& *%+,$-+& ./& 0%"1+.2& 3.11%$"-4.2& 5.//434"$& 6%2%& +78#.$+9)& $%&'()*# +,+%-'.'# /.+#











H< C71D# .'# 21,(+.,)3# .,# >1(7# %.'('# 19# %.0.3# 3)0),3),(%-# *)6&%+()3# 6),)'# ;7.27# ;)*)#
1>(+.,)3# 9*15#0+(()*,# ')+*27# +,3# 9*15#3.'(+,2)#5)+'&*.,6<#=%%# C71D# +''12.+(.,6#
IJK:#I=L#+,3#IMN#0*1().,'#+*)#1,%-#'%.67(%-#&0*)6&%+()3#4@#A:O#91%38<#P7&':#C71D#
.'# 2+&'+%%-# %.,Q)3# (1# '(+(.,# +2(.1,# 40*1>+>%-# >)2+&')# 19# .('# 9+*,)'-%# +,3#
6)*+,-%6)*+,-%#5)5>*+,)#+,271*'8<#
#
R< C71D#;+'#0*)/.1&'%-#+'2*.>)3#+#*1%)# .,#*)6&%+(.1,#19#+010(1'.':::'((#+,3# .,# .,3.*)2(#
*)6&%+(.1,#19#5)5>)*'#19#(7)#S*&00)%#T.Q)#K+2(1*#4STK8#0*1().,'#4'))#"#$%&'!()#+,3#






















































































































KLF6  mRNA fold change after Simvastatin treatment
#
RhoB CTL 1!M Sim 10!M Sim 1mM MA 
1!M Sim + 
1mM MA 
10!M Sim + 
1mM MA 
2h 364  462 409  642 
12h 601  2809 622  886 
24h  
(2 Exp) 







Simvastatin leads to RhoB upregulation on protein level 
$%# &'%(# )*+,-)./01%2# %3# 4'%5# *+%0,12# 12# 6178/&0/012# 0+,/0,9# 9133,+,201/0,9# ')7/2#
&:,.,0/.# 7)&;.,# <9'6=>?# ;,..&@# (,# *,+3%+7,9# (,&0,+2# A.%0# /2/.B&1&# (10'# 0%0/.# ;,..#
.B&/0,&C# $',+,3%+,# 0(%# ;%77,+;1/..B# /8/1./A.,# /201A%91,&# <%2,# 7%2%;.%2/.# /29# %2,#





"#$%&'(! )*+C# K# 2%01;,/A.,# )*+,-)./01%2# %;;)+&# /.+,/9B# /30,+# 0+,/07,20# (10'# L!>#
















)&,9C# 4'%5# 1&# /.7%&0# )29,0,;0/A.,# 12# )20+,/0,9# ;%20+%.# ;,..&# <O$P?# A)0# 12;+,/&,&# (10'# +1&12-#
6178/&0/012#;%2;,20+/01%2&C#60+%2-#4'%5#)*+,-)./01%2#1&#81&1A.,#(10'#;%2;,20+/01%2&#/A%8,#L!>C#







('%.,#*+%0,12# 12#&:,.,0/.#7)&;.,#;,..&C' R2#%+9,+# 0%#9,0,;0# 0',#&7/..#/7%)20&# %3#4'%5@#
 CTL       0,1 !M   1 !M    10 !M    20 !M 
               Sim.       Sim.     Sim.      Sim. 
RhoB 
Actin 
 CTL       0,3 !M   1 !M    3 !M    10 !M 





$%&'(#%)*+,-.#*/#0&*-(1,#2%3# -*#4(#+.(35# 62+.# -2(# 4%,3.# */# -2(# $*%31,'#7*,-&*$.#%&(#
*/-(,#,*-#7$(%&$8#.(0%&%-(3#9.((#6+4+$1,#4$*-#1,#!"#$%&'()'*+,##
:(7*,3;# %7-1,# $(<($.# %&(# .*)(-1)(.# 1,<(&.($8# 0&*0*&-1*,%$# -*# =2*># $(<($.# 9.((# ?7-1,#
4$*-# 1,# !"#$%&' ()' -+5# ?# &(%.*,# /*&# -21.# 02(,*)(,*,# 7*+$3# 4(# 7%.0%.(# %7-1<%-1*,# 1,#
:1)<%.-%-1,#-&(%-(3#32:@A#7($$.!!"#B2172#B(#%$.*#.2*B#$%-(&#*,5#?7-1,#B%.#*,(#*/#-2(#
/1&.-# .+4.-&%-(.#3(.7&14(3# /*&#7%.0%.(.CDD5#6*#71&7+)<(,-# -21.# 0&*4$();# -2(#7($$.#2%<(#
4((,# $8.(3# 1,# $8.1.# 4+//(&# 0&1*&# -*# -2(# %331-1*,# */# !E# F%())$1# 4+//(&# %,3# 0&*-(1,#












Simvastatin induced RhoB is active 
K,# *&3(&# -*# 0(&/*&)# 1-.# 7($$+$%&# /+,7-1*,.;#=2*>#,((3.# -*# 4(# 1,# %,# %7-1<(;#L6MN4*+,3#




3(-(&)1,(3# <1%# >&%3/*&3# %..%85# GH+%$# %)*+,-.# */# 0&*-(1,# B(&(# 1,7+4%-(3#B1-2# (H+%$#
%)*+,-.#*/#=>PNL:6N.(02%&*.(#/*&#*,(#2*+&5##
#
R,/*&-+,%-($8# -2(# =2*-(O1,# 41,31,'# 3*)%1,# 0&(7101-%-(.# %$.*# .(<(&%$# *-2(&# 0&*-(1,.#
4(.13(.#=2*>;#B2172;#-*'(-2(&#B1-2#-2(#$*B#=2*>#.0(71/171-8#*/#-2(#%<%1$%4$(#%,-14*31(.;#
(E0$%1,.# B28# -2(&(# 1.# )*&(# -2%,# *,(# 0&*-(1,# <1.14$(# *,# -2(# ,1-&*7($$+$*.(# )()4&%,(#
%/-(&#1))+,*#3(-(7-1*,5##
?# 7*,7(,-&%-1*,# 3(0(,3(,-# 1,7&(%.(# 1,# %7-1<(# =2*># %/-(&# :1)<%.-%-1,# -&(%-)(,-# 7%,#
7$(%&$8# 4(# .((,# 1,# !"#$%&' (.' *+5# A*&(*<(&# -2(# +0&('+$%-1*,# %,3# %7-1<%-1*,# B%.#




 CTL         10!M       10Sim.      1mM     
                  Sim.        +MA           MA 
!!"
#$%$&'(")*+,&*(-".$&$"/$&0*&1$2",*"$3)(42$"'+"4+-/$)505)"/4((2*.+"!"#$%&'"()*+,,6"75&-,"




9;$" -$)*+2" )*+,&*(" .'-" /$&0*&1$2" 0*&" 4+5+)4?',$2"<=>")*4/($2"8#9:-$/;'&*-$6" B+"
,;5-" )'-$" *+(@" *+$" ?'+2" '," '&*4+2" CDE>'" ?$)*1$-" %5-5?($6" #5+)$" '((" <=>:/4((2*.+"















"#$%&'! ()*! +,-.'/#0! 12.#31.#-0! 14415*! 2;#HI" )$((-" .$&$" ,&$',$2" .5,;" #51%'-,',5+" J#516K"
'+2L*&" 1$%'(*+5)" ')52" JIMK" 0*&" NO" ;*4&-6" PQ4'(" '1*4+,-" *0" 5+)4?',$2" )$((" (@-',$-" JNCR!G"
/&*,$5+K".$&$"5+)4?',$2".5,;"NSR!T".$,"%*(41$"J)'6"DD!T"2&@"%*(41$K"<=>:8#9:-$/;'&*-$"0*&"
N;6" 'K"<;*=".$-,$&+"?(*,6" 9;$" -1'(($&" ?'+2"'," SDE>'"-;*.-"<;*=".;5($" ,;$" ,;5)E$&" ?'+2"',"
'//&*351',$(@"SUE>'"1*-,"/&*?'?(@"'&5-$-"0&*1"4+-/$)505)"?5+25+G"*0",;$"'+,5:<;*="'+,5?*2@",*"
 CTL    0,1!M   1!M   10!M   0,1!M  1!M    10!M      
             Sim      Sim     Sim.    Sim.     Sim.     Sim.      
                                               1mM    1mM    1mM   1mM 
                                                 MA      MA       MA     MA 
– active RhoB 
b) 
c) 
 CTL       10!M   |    CTL     10 Sim   | Rhotekin 
                Sim     |    + Sepharose     |   beads 
– RhoB 
– RBD domain 
30 kDa – 
21 kDa – 
a) 
!"#
$%&'()*# +(&# ,*&')-%.# /0# 12$%'-'$'-3)# $%$456-6# &7# +(&8# /$%96# $6# 9)')*:-%)9# /5# ;:$<)=# <)4#
$%$45>)*.# ?0# @2449&A%# ?&%'*&46B# C-*6'# 'A&# ,*&/)6# $7')*# ,2449&A%.# @*&/)6# '(*))# $%9# 7&2*# A)*)#
-%?2$/$')9# A-'(# DEFG6),($*&6)# A-'(&2'# ?&2,4)9# +8H# 9&:$-%.# I%-%?2/$')9# +8HGDEFG
6),($*&6)#6(&A6#$#/$%9#$'#$,,*&J.#K"LH$#A(-?(#-6#,*&/$/45#'()#9)''$?()9#+8H#9&:$-%.!























8(*9$:'$'(3# <&+# >(<<2+23'# '(*2:0# =<'2+# '+2$'*23'# 4(',# F6!7#8(*9$:'$'(3# <&+# 5!,# :'+&3.#
*&+%,&-&.()$-#),$3.2:#)&;->#?2#&?:2+92>0#1,2#<(?+&;:#%,23&'/%2#&<#*/&';?2:#(:#-&:'@#
)2--:# >2''$),# <+&*# ',2# :;+<$)2# $3># :,&4# '/%()$-# +&;3>2>#$%&%'&'()# :'+;)';+2:0# E(.,2+#
>&:2:#-2$>#'&#+&;3>(3.#G;()B-/@#?;'#4(',#23&;.,#'(*2#2923#-&4#)&3)23'+$'(&3:#&<#6@F!7#
8(*9$:'$'(3# -2$># '&# >2''$),*23'# &<# ',2# )2--:0# !"#$%&' ()# :,&4:# ',2# ),$3.(3.#
*&+%,&-&./# &<# $# >,8H7#)2--# -$/2+# $<'2+# 5!7#$3>#56!7#8(*9$:'$'(3# '+2$'*23'# <&+# FI#
,&;+:0#
#
Caspase-3 and 2 are activated in parallel to RhoB 
1,2# *&+%,&-&.()$-# ),$3.2:# :;..2:'# (39&-92*23'# &<# $3# $%&%'&'()# %+&)2::0# 1,(:# ,$:#
?223# )&3<(+*2># ?/# )$:%$:2JK# $)'(9$'(&3# (3# >,8H7# )2--:# $<'2+# '+2$'*23'# 4(',#
8(*9$:'$'(3#*!"#$%&'(('+,,#$:#('#,$:#?223#:,&43#?2<&+20##$#L;+',2+*&+2#42#:,&4#',$'#
)$:%$:2J5#(:#$)'(9$'2>#?/#8(*9$:'$'(3#(3#$#'(*2#>2%23>23'#*$332+@#'&&#*!"#$%&'(('-,,0##
M$:%$:2JK# (:# $# )23'+$-# 2<<2)'&+# )$:%$:20# 1,;:@# (':# $)'(9$'(&3# :,&4:# )-2$+# &3.&(3.#
$%&%'&:(:# 0#=<'2+#F",#&<# '+2$'*23'#4(',#F6!7#8(*9$:'$'(3#42#*2$:;+2>#$3# $)'(9('/#&<#
$?&;'# 5K6N# (3# +2-$'(&3# '&# $3# ;3'+2$'2># )&3'+&-0# O(',# ',2# :$*2# )&3)23'+$'(&3# &<#
8(*9$:'$'(3@# 3&#)$:%$:2JK# $)'(9$'(&3#4$:# >2'2)'$?-2#$<'2+# ",0#8;+%+(:(3.-/#$<'2+# K,#&<#
'+2$'*23'# )$:%$:2JK# 4$:# 2923# &3-/# I6N# $:# $)'(92# $:# (3# )&3'+&-# )2--:0# P$+-/# Q,&R#
$)'(9$'(&3#)&;->#%-$/#$3#(*%&+'$3'#+&-2#(3#',(:#%,23&*23&3@#:(3)2#Q,&R#(:#B3&43#<&+#(':#
+&-2#(3#%&:('(92#$3>#32.$'(92#+2.;-$'(&3#&<#$%&%'&:(:0#
M$:%$:2J5# :,&4:# $# 92+/# :(*(-$+# $)'(9$'(&3# %$''2+3# 4(',# F6!7# 8(*9$:'$'(3@# $-',&;.,#
;%+2.;-$'(&3# &<# '&'$-# $)'(9('/# +2$),2:# &3-/# FSIN# $<'2+# F",0# O2# ;:2># $# )$:%$:2J5#
(3,(?('&+@#4,(),#42#$>>2>#>(+2)'-/#'&#',2#)2--#>(:,2:#(3#$#<(3$-#)&3)23'+$'(&3#&<#5!70#O(',#
',(:#(3,(?('&+#('#4$:#%&::(?-2#'&#>2'2+*(32#3&'#&3-/#',2#'&'$-#)$:%$:2J:;?:'+$'2#)-2$9(3.#
$)'(9('/# &<# ',2# -/:$'2:@# ?;'# (3# <$)'# ',2# :%2)(<()# $)'(9('/# &<# )$:%$:2J50# 1,2+2<&+2# 42#
:;?:'+$)'2>#',2#+2*$(3(3.#;3:%2)(<()#$)'(9('/#&<#(3,(?('&+#'+2$'2>#)&3'+&-#$3>#8(*9$:'$'(3#
'+2$'2># )2--:# <+&*# ',2# '&'$-# $)'(9('/# 9$-;2:# $3># )$-);-$'2># ',2# $)'(9('/# (3# +2-$'(&3# '&#
)&3'+&-#)2--:#$.$(30##
!"#




,(#.:%(';(0#&/#&8+=;=+2# =/1=:=+=./#.-#645A47>#?.#0(+('D=/(# =-# +1=%#8&%9&%(5F# =/1=:=+=./#
,&%# &/# =/0='(8+# (--(8+# .-# 8&%9&%(53# =/1=:=+=./# .'# H)%+# )/%9(8=-=+2# .-# +1(# 8&%9&%(53#
=/1=:=+.'G#,(#&00(0#+1(# =/1=:=+.'# +.# *2%&+(%#:(-.'(#D(&%)'(D(/+# =/%+(&0#.-#&00=/<# =+# +.#
+1(#<'.,=/<#8(**%>#?1(#%&D(#(--(8+%#8.)*0#:(#.:%(';(0G#,1=81#*(&0%#+.#+1(#8./8*)%=./#
+1&+#+1(#=/1=:=+.'#1&%#%.D(#%9(8=-=8=+2#-.'#8&%9&%(5FG#+..#IJ&+&#/.+#%1.,/K#?1(#9'.:(%#
)%(0# -.'# !"#$%&' ()# ,('(# +'(&+(0# ,=+1# 8&%9&%(53# =/1=:=+.'# ./*2# %1.'+*2# :(-.'(#
D(&%)'(D(/+># $# %(8./0# D(&%)'(D(/+# %1.,(0# +1&+# 8&%9&%(5F# &8+=;=+2# ,&%# &*%.#
=/1=:=+(0L>##




M.D9*(+(# '(;('%=:=*=+2# .-# 8&%9&%(53# &8+=;&+=./# I;&*)(%# (;(/# *.,('# +1&/# =/# +1(# 8./+'.*#
8(**%L#8&/#:(# &81=(;(0#:2#&00=/<#@DB#B$# +.#01CNB#8(**%# =/# 9&'&**(*# +.#C=D;&%+&+=/>#
E(#&*%.#+'=(0#+.#'(;('%(#+1(#(--(8+#:2#&00=/<#@4!B#O&'/(%2*#92'.91.%91&+(#IOPPL#&/0#
@4!B#Q('&/2*<('&/2*# 92'.91.%91&+(# IQQPPLG# '(%9(8+=;(*2># QQPP# 1&0# /.# (--(8+# :)+#
OPP#8.)*0#'(%8)(#&'.)/0#647#.-#@4!B#C=D;&%+&+=/#=/0)8(0#&9.9+.+=8#&8+=;=+2>##






















17:>?' 2&@@,' "0' +' 3";&.' +01' 2802&03%+3"80' 1&-&01&03' ;+00&%)' $%&# '()*+')*,-# ,.# /,)%#




(&>>0# 9C$K=?# C'01'0&86# *-%*/*),2# '>0,# *-%*/*)0# ('01'0&8D# '()*+*)5# +&25# &..&()*+&>5?# C,-)2,>0# '-4#
)2&')&4#(&>>0#/,)%#0%,E#('01'0&8D#>&+&>0#,.#'2,A-4#LFG#,.#C$K#')#'>>#B&'0A2&4#)*B&1,*-)0?#$E,#
*-4&1&-4&)#&M1&2*B&-)0#E&2&#(,B/*-&4#*-),#,-&#.*3A2&?#5=#C'01'0&86#(,A>4#/&#'()*+')&4#A1#),#
INLG# ,.# C$K# '.)&2# IH# %,A20?# 7,2&,+&2# '# 4,E-2&3A>')*,-# /5# LFG# (,A>4# /&# ,/0&2+&4# '.)&2# H#
%,A20?#C'01'0&86#*-%*/*),2#2&4A(&4#('01'0&86#0A/0)2')&#(>&'+'3&#*-#(,-)2,>#(&>>0#/5#('?#6F86LG#
')#'>>#)*B&1,*-)0?#2=#C'01'0&86#*0#/&*-3#'()*+')&4#E*)%#2*0*-3#@*B+'0)')*-#(,-(&-)2')*,-0?##











0?&' @AB=C2D' %&:$;06-&' <60?>61' "7' :?4EA' ;&//-' 0%&60&:' 32%' (F' ?2$%-*'$%&'()*+,# ',+-#
.$/0# 12$30# 4%5'*6(4%5'*6(# 765)78)978':%# .;;<<0#1"!$3#'*-# ='5*%96(# 765)78)978':%# .><<0#
1"!$3?'@7%,+=+,# ',:+&+:6# &'(A%9#B%5%#)C:'+*%-#C6#'--+*4# ,'97'9%DE# +*8+C+:)5# :)# (69':%9# 98)5:(6#
C%=)5%#A9%?#F8+(%#8+48%5#,)*,%*:5':+)*9#)=#@+2&'9:':+*# +*-A,%#,'97'9%DE0#"01!$# :)# 5%-A,%# +:9#
',:+&+:6?# $/# 5%-A,%9# @+2# +*-A,%-# ',:+&+:6# :)# (%&%(9# ()B%5# :8'*# ,)*:5)(?# $/# '()*%# 9:5)*4(6#
',:+&':%9#,'97'9%DE?#;;<<#'*-#><<#,)A(-#)*(6#5%-A,%#@+2#+*-A,%-#%==%,:9#C6#'#92'((#%G:%*:?#
;<<# '()*%# +*-A,%9# ,'97'9%DE# ',:+&+:6# B8+(%# ><<# ',:9# *%A:5'((6?#!"#$%&'()*+, -../., #'.*, *0/1,
*('23'.3,3)4%'(%/2+,5'*6'*)78, %20%#%(/., .)3"&)3,9)'*".)3,'&(%4%(%)*, %2,'$$, 6./#)*, (/,', $)4)$,/:,
;<7=<>,/:,&/2(./$,&)$$*+,,
#
Simvastatin treatment leads to a loss of RhoB’s vesicular 
localization pattern 
H22A*)8+9:),8%2+9:56# )=# -8@I$#,%((9# 45)B*#)*# 97%,+'(# ,)&%5# 9(+7# -+98%9# 98)B9# :8%#








"$!%#&'()*+,*,'-#*-.#"(%#%/#01*.+#,2# ,31# '-,141+,'-5#26+14)*,'2-# ,3*,#7328# '+#+,'00#
*69-.*-,#69,#*#)1+':90*4;0'<1#02:*0'=*,'2-#>*,,14-#61:2(1+#)'+'601#*5*'-?##





!"#$%&' ()*' +,,$-./0$.%&12&-&' 3,.-.20.-40' 56.7' 4-8"9.:;<' 4/8&%' =>6' 8%&48,&-8' ./'












Lethal toxin upregulates RhoB 
$%&'($# &)*+,# -./0# 12)3#!"#$%&'(')*+ $#&(,""''# 4%(5&+6(&%7# 8(7# 92)&%+,7# :'+5'# $%(47# &)# (#
7;<7%=;%,&# ;92%>;$(&+),# )1# 8')# 92)&%+,7?# @AB# 9(&+%,&7# :')# (2%# +,1%5&%4# :+&'# &'+7#
9(&')>%,#7'):#7+3+$(2#7C%$%&($#3;75$%#5%$$#4(3(>%#(7#9(&+%,&7#;,4%2#D&(&+,#&2%(&3%,&#
4)?#E)2%)6%2# (,# ;92%>;$(&+),# )1#8')F# +,# 1+<2)<$(7&7# (7# (# 2%7;$&# )1# ./# &2%(&3%,&# '(7#
($2%(4G#<%%,#9;<$+7'%4?#H%#;7%4#&'+7#7G7&%3#(7#(#5)39(2+7),#&)#D+36(7&(&+,#(,4#:%#
5);$4# 7'):#(,# ;92%>;$(&+),# )1#8')F# +,# ./# &2%(&%4# 4'DIE#5%$$7# +,# (# &+3%#4%9%,4%,&#
3(,,%2# !"#$%&'( )*+,# J,# +,52%(7%# +,# 8')F# $%6%$7# +7# ($2%(4G# 6+7+<$%# (1&%2# K# ');27#
+,5;<(&+),#:+&'#L!>M3$#./?#J3);,&7#+,52%(7%#),$G#7$+>'&$G#;,&+$#L"'N#<;&#,)#3)2%#8')F#
+7# 4%&%5&(<$%# (1&%2# "K'?# @):%6%2# &'%# (55)24+,># $)(4+,># 5),&2)$# +7# ($7)# 6%2G# $):?# A,#




2+7+,># 5),5%,&2(&+),7?# A&# +7# 9)77+<$%# &'(&# &'%# 5),5%,&2(&+),7# 5')7%,# :%2%# ($2%(4G# &))#











!"#$%&' ()*' +,-.&-/%0/",-' 0-1' /"2&' 1&3&-1&-.4' ,5' 67,8' $3%&#$90/",-' "-' 17:;<' .&99='
$-1&%' 9&/709' /,>"-' /%&0/2&-/' 05/&%' ?@' 7,$%=*' 0A# R%$$7# :%2%# &2%(&%4# :+&'# 4+11%2%,&#
5),5%,&2(&+),7# )1# ./# 1)2# L"# ');27?# D&2),>%7&# 8')F# ;92%>;$(&+),# 5);$4# <%# 4%&%5&%4# :+&'# (#




 CTL     LT       LT        LT       LT       LT 
 24h      1h       4h        8h      12h      24h 
– Tubulin 
 CTL     LT        LT       LT      LT  




C3 inactivates RhoB  
$"# %&# '# (')*+,%'-# *./%0# 1,.2#!"#$%&'(')*+,#%)"'-)*# 34%)4# 5+')*%6'*+&#74.#8,.*+%0&# (9#




$"# H# G<# *,+'*+5# )+--# -9&'*+&I# '# ('05# &4%1*# 5A+# *.# JK=L,%(.&9-'*%.0# %&# .(6%.A&># <4%&#
+0&A,+&# *4'*# $"!&# %&# +0M92'*%)'--9# ')*%6+># N.,+.6+,# *4+# +/8+,%+2+0*# &4.3&# *4'*# $"#
&++2&#0.*#*.#4'6+#'0#%0*+0&+#%01-A+0)+#%0#,+:A-'*%.0#.1#*.*'-#74.B#'2.A0*&>##





















0@-%21;! 091'&! :)! ,-%&;*! <4%&# (-.*# ).01%,2&# 74.B# A8,+:A-'*%.0# A8.0# CP!N# @%26'&*'*%0#
*,+'*2+0*># $"# 5.+&# 0.*# '-*+,# *.*'-# 74.B# -+6+-&># C!:E2-# -+*4'-# *./%0# %05A)+&# 74.B# &-%:4*-9>#
?0*+,+&*%0:-9I#@%26'&*'*%0# %05A)+5#74.B#A8,+:A-'*%.0# %&#+6+0#+04'0)+5#(9# *4+#'55%*%.0#.1#$">#
<4+#+11+)*#.1#$"#.0#G<#%05A)+5#74.B#%&#0.*#).28-+*+-9#)-+',#1,.2#*4%&#(-.*I#34%)4#2%:4*#(+#*4+#
,+&A-*#.1#'#3+**%0:#8,.(-+2#.0#8',*&#.1#*4+#-'&*#-'0+>#
 CTL     10 !M    1!g/ml   1!g/ml   1!g/ml    1!g/ml 
              Sim          C3          LT         C3          C3 
                                                       10!M     1!g/ml 
                                                         Sim         LT 
unspecific band 
RhoB 
  CTL                           1!g/ml 2!g/ml 1!g/ml 2!g/ml 1!g/ml 2!g/ml  
                                        LT      LT        LT        LT         LT      LT 
            1!g/ml  3!g/ml                        1!g/ml 1!g/ml 3!g/ml 3!g/ml  
               C3        C3                              C3        C3        C3      C3 
– RhoB 
– ribosylated RhoB 
 unspecific band 
!"#
Treatment with Simvastatin, lethal toxin and C3 
# #
# #






G-1A2*'2-&# J# =78&5>1)# $?# 5?# =8!C# G-1A2*'2-&# J# 7"8&5>1)# $?<# K-B'6(.*# 3.(.# '2E.&# 3-',# 2#
B%&+%B2)#)2*.(#1-B(%*B%0.#3-',#2#78/#%;L.B'-A.<#
#
M&'(6-5-&5)@N# 1%(0,%)%5-B2)# B,2&5.*# :%# &%'# 2)32@*# B%((.)2'.# 3-',# B2*02*.# 2B'-A2'-%&<#
F,.&#3.#0.(+%(1.:#B2*02*.#2**2@*#%&#$?#'(.2'.:#B.))*N#2&# -&B(.2*.#%+#!# '%#H# '-1.*#
B%102(.:# '%# B%&'(%)# B.))# 2B'A-'-@# 32*# A-*-;).# 2+'.(# 7",# !"#$%&'( )*+N# 2))# B.))*# ,2A.#








#0" &'*1&/*%&" '*+2(&+" 3%" )$/4(*&*" '$2%53%-"1%5"5*&1)6/*%&" $7" &6*"2%5*'-'$2%5"$7" 1((" )*((+8"9>"
#*((+" &'*1&*5" 93&6" ,!-./(" (*&61(" &$:3%" +6$9" /$'46$($-3)1(" )61%-*+" $%(;" 3%" 1" '*(1&3<*(;" +/1(("
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C3 mediated inactivation of RhoB in LT induced apoptosis  
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RhoB cleavage by caspase-2? 
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– 48kDa Caspase-2L precursor 
– 35kDa Caspase-2S precursor 
 
 










– 30kDa Caspase-2 L fragment p30 
#
– unspecific band 
– RhoB  
    CTL        10 !M      10!M        2!M 
                    Sim.         Sim.         INH 
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